Skip to content

Consequences and Risk factors Of congenital CytomegalovirUS infection

Consequences and Risk factors Of congenital CytomegalovirUS infection - CROCUS-study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39637
Enrollment
25000
Registered
2012-07-25
Start date
2012-10-15
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital CMV infection congenital cytomegalovirus infection

Interventions

None listed

Sponsors

RIVM
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: - Children who underwent neonatal screening and of whom the dried blood spot is stored for 5 years. (Phase 1, n

Exclusion criteria

Exclusion criteria: - Children who did not participate in neonatal screening - Chidren whose dried blood spots are not stored for 5 years - No informed consent of parents for testing the dried blood spots or participation in the study

Design outcomes

Primary

MeasureTime frame
Hearing function at the age of 5 to 6 years

Secondary

MeasureTime frame
- Neonatal hearing function and cognitive function, motor function, visual function and growth during childhood (0 to 6 years) - Quality of life of the children (at the age of 5 to 6 years) and of their parents. - Viral load of CMV in the dried blood spots. Additional study: - Predictive factors for the outcome of congenital CMV infection.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)